Status:

RECRUITING

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

Lead Sponsor:

Lindsay Maguire, MD

Conditions:

Suicide

Suicidal Ideation

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intraveno...

Detailed Description

In this phase one trial, the investigators' objective is to establish the safety and feasibility of the study dose and route of administration, as well as to provide preliminary data on efficacy in re...

Eligibility Criteria

Inclusion

  • Acutely Suicidality ("yes" answer to any of items 4 or 5 on C-SSRS "Suicidal Ideation" category)
  • Require inpatient stabilization for SI or actions based on clinical observation and interview
  • Are accepted for psychiatric stabilization at the University of Kansas Medical Center's Strawberry Hill campus
  • Have a Glasgow Coma Score (GCS) of 15
  • Age 18-65

Exclusion

  • Current or past history of psychosis
  • Current or recent (past 4 weeks) symptoms of mania/hypomania as defined by Young Mania Rating Scale (YRMS) score of 12 or greater
  • History of ketamine use disorder
  • History of liver transplant
  • Pregnancy or breastfeeding
  • Imprisonment or inability to consent
  • Positive urine drug screen or serum alcohol level
  • Hypertension (SBP \> 160 or DBP \> 100 before administration of ketamine)
  • Hypotension (SBP \< 90)
  • Presence of acute medical condition requiring admission to medical service
  • Allergy, intolerance, or previous adverse reaction to ketamine
  • Patient has 8+ lifetime ketamine exposures
  • The treating physician determines that the patient is not a good candidate for the study (e.g. medical condition/procedure, medication that would contradindicate ketamine treatment)

Key Trial Info

Start Date :

May 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06085937

Start Date

May 1 2024

End Date

April 1 2026

Last Update

July 10 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Kansas Strawberry Hill Campus

Kansas City, Kansas, United States, 66101

2

University of Kansas Medical Center Emergency Department

Kansas City, Kansas, United States, 66160